The global exchange market often witnesses the U.S. and Canadian dollars competing for dominance. A similar scenario can be observed in the magic mushroom industry. There is a surge in the number of online magic mushroom dispensaries in Vancouver and other cities. But, will they be able to match the rapid advancement of the psychedelic sphere in America? Let’s delve deeper.
[toc]
Main Takeaways:
- Oregon was the first state to legalize therapeutic use, with certified practitioners administering it.
- In 2020, Canada’s Health Minister gave four terminally ill cancer patients the green light to use magic mushrooms for palliative care.
- Clairvoyant is a 24-week Phase 2 trial at the University of British Columbia exploring psilocybin-assisted therapy for adults suffering from alcohol abuse disorder.
The Rapid Growth of the Magic Mushroom Industry in the United States.
In the U.S., the magic mushroom industry has quickly expanded, rivaling cannabis as the leading narcotic. This swift growth signifies a burgeoning societal acceptance of the substance’s potential for therapeutic use.
Prioritizing Mental Health
Medical professionals are captivated by its potential to alleviate symptoms of mental disorders such as depression, anxiety, and PTSD. Promising study results have spurred private pharmaceutical companies to explore its medicinal benefits.
This trend has not only sparked interest in healthcare applications but has also significantly boosted the economy. Startups and research projects are focusing on the development of psilocybin.
Clinical evidence supporting the use of magic mushrooms in treating specific diseases is increasing. NIDA Director Nora Volkow emphasized the growing evidence that psychedelics have “significant potential” for medical treatments.
Legal Milestones
- Oregon Measure 109: In 2020, Oregon set a precedent by becoming the first state to legalize psilocybin for therapeutic use, allowing to administer controlled doses. This significant judgement has established a standard for other states to emulate.
